Incyte advances its Opzelura eczema campaign with a ‘reimagine’ theme
Incyte’s newest campaign for Opzelura (ruxolitinib) encourages itchy patients to “Reimagine Relief” as it works to carve out a niche in the crowded eczema treatment …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
